GPR143P

Across TCGA pan-cancer cohorts, GPR143P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated GPR143P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher GPR143P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GPR143P expression acts as an unfavorable survival marker, although some lineages such as HNSC and LGG show a favorable association.

OV, LIHC, and BLCA are the cancer types where GPR143P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.261	0.845	<.001	90	view →
LIHC	OS	Tertile	All	0.059	0.775	<.001	57	view →
BLCA	OS	Tertile	All	0.069	0.688	<.001	54	view →
DLBC	OS	Tertile	III,IV	0.172	0.907	<.001	45	view →
KIRP	DFS	Tertile	All	0.551	0.621	.013	21	view →
CHOL	OS	Tertile	III,IV	0.136	0.859	.003	18	view →
THCA	DFS	Tertile	III,IV	0.824	0.919	.027	12	view →
HNSC	DFS	Tertile	II,III,IV	0.745	0.660	.027	6	view →
LGG	OS	Tertile	All	0.667	0.455	.032	3	view →
KICH	OS	Tertile	All	0.857	0.973	.025	3	view →
LUSC	DFS	Median	III,IV	0.723	0.516	.041	1	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

GPR143P–OV (OS)

Open the OV breakdown →